B+
Bull case
25%
Probability
Target price
$12.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
ANNX
AnnexonANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
ANNX has multiple dated 2026 catalysts across two advanced programs: ARCHER II Phase 3 data in GA and a planned tanruprubart BLA supported by FORWARD data. Positive early FORWARD outcomes and a strengthened runway could support a meaningful re-rating if execution continues [#SEC-8K-2026-08-12].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Binary Phase 3 efficacy and safety risk for ARCHER II.
Momentum
9
Value
41
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.50 · Bull $12.00 · Bear $2.50Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $15.50
Why
Momentum9 · Δ7d -3.5
Value41 · Δ7d 0.0
Sentiment100 · Δ7d 0.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Binary Phase 3 efficacy and safety risk for ARCHER II.
- • Clinical-development delays or weaker-than-expected FORWARD or ANX1502 results.
- • The thesis remains highly binary: ARCHER II could disappoint, the FDA could require additional generalizability data for tanruprubart, and delays could increase financing or dilution risk.
Catalyst clock
2026-09-30
Improved balance-sheet runway
Lead driver: Sentiment · See AI snapshot
Momentum
9
9% active weight
Current posture
7d trendFlat
Δ7d
-3.5
Δ21d
-15.5
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
100
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+1.0
Why this grade
Composite grade A. Momentum 9.0 / Value 41.2 / Sentiment 100.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$6.50
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.50
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$972.54M
Beta
1.17
Shares Out
163.84M
P/E (TTM) · Derived
-4.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-5.42
Rev YoY
-
EPS YoY
-19.9%
Gross Margin
-
Op Margin
-
Net Debt
-$212.14M
Current Ratio
5.53
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data